Ghassan Mouneimne, PhD (IMAGE)

University of Arizona Health Sciences

Ghassan Mouneimne, PhD

Caption

University of Arizona Cancer Center member Ghassan Mouneimne, PhD, says he is hopeful the new study is a step closer to the MeCo Score gaining U.S. Food and Drug Administration approval as a diagnostic tool, so it could be used to help people with breast cancer.

Credit

Photo by Joshua Elz, University of Arizona Cancer Center

Usage Restrictions

Credit Joshua Elz, University of Arizona Cancer Center

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.